The trading price of Petros Pharmaceuticals Inc (NASDAQ:PTPI) closed lower on Monday, April 14, and closing at $0.05, -3.36% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $0.0416 and $0.046. In examining the 52-week price action we see that the stock hit a 52-week high of $0.91 and a 52-week low of $0.04. Over the past month, the stock has lost -45.50% in value.
Petros Pharmaceuticals Inc, whose market valuation is $2.46 million at the time of this writing, is expected to release its quarterly earnings report on 2024-Nov-12. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0 per share this quarter, however they have predicted annual earnings per share of 0 for current year and 0 for next year.
On the technical side, indicators suggest PTPI has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that PTPI’s price is currently -35.48% off the SMA20 and -62.65% off the SMA50. The RSI metric on the 14-day chart is currently showing 35.67, and weekly volatility stands at 19.09%. When measured over the past 30 days, the indicator reaches 22.42%. Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s beta value is currently sitting at 2.16, while the Average True Range indicator is currently displaying 0.02.
To see how Petros Pharmaceuticals Inc stock has been performing in comparison to its peers in the industry, here are the numbers: PTPI stock’s performance was -3.36% in the latest trading, and -94.95% in the past year.
An evaluation of the daily trading volume of Petros Pharmaceuticals Inc (NASDAQ:PTPI) indicates that the 3-month average is 35.19 million. However, this figure has increased over the past 10 days to an average of 11.24.
Currently, records show that 53.52 million of the company’s shares remain outstanding. The insiders hold 18.16% of outstanding shares, whereas institutions hold 1.82%. The stats also highlight that short interest as of 2025-03-31, stood at 1.48 million shares, resulting in a short ratio of 0.04 at that time. From this, we can conclude that short interest is 532.00 of the company’s total outstanding shares. It is noteworthy that short shares in March were up slightly from the previous month’s figure, which was 0.35 million. However, since the stock’s price has seen -88.32% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
